Sign In
Last checked at 
23 Oct 2015 07:00
FOR IMMEDIATE RELEASE | 23 OCTOBER 2015 |
BOARD CHANGE
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that Ajay Agrawal has stepped down as Non-Executive Director with immediate effect.
Tim McCarthy, Non-Executive Chairman said: "We would like to thank Ajay for his contribution whilst at ImmuPharma.
"In the short period of time as Chairman, I have become more convinced of our lead programme Lupuzor. This has the potential to bring success for ImmuPharma, reward our long standing shareholders and ultimately to provide a significant treatment for lupus sufferers, globally. I am delighted to be part of the team driving this strategy forward."
-Ends-
For further information please contact:
ImmuPharma plc | + 44 (0) 20 7152 4080 |
Tim McCarthy, Chairman | |
Lisa Baderoon, Head of Investor Relations | + 44 (0) 7721 413496 |
Panmure, Gordon & Co., NOMAD & Broker | +44 (0) 20 7886 2500 |
Fred Walsh, Duncan Monteith, Corporate Finance Charles Leigh-Pemberton, Corporate Broking
| |
Follow the stocks
